Equities

Biostax Corp

BTAX:PKC

Biostax Corp

Actions
  • Price (USD)0.036
  • Today's Change0.00 / 0.00%
  • Shares traded314.00
  • 1 Year change-92.80%
  • Beta-0.0666
Data delayed at least 15 minutes, as of May 17 2024 16:18 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Biostax Corp. is a developer and marketer of pharmaceutical, biotechnology, and MedTech products. The Company has partnerships in the fields of autoimmunity and immune restoration and are able to deliver solutions today for people that are living with autoimmunity, chronic inflammation, infection, and cancer. Its internal and partner programs comprised of JKB-122, an investigational small molecule, long-acting toll-like receptor 4 (TLR4) antagonist developed for autoimmune hepatitis, nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) that has demonstrated anti-fibrotic, immuno-modulating, and anti-inflammatory activities in preclinical models; Lodonal, is a once-a-day immune system regulator for the management of human immunodeficiency virus and acquired immune deficiency syndrome (HIV/AIDS), and LDN, which is a compound formula that is purported to provide immune-modulating benefits that include cancer, pain, autoimmune, and anti-aging.

  • Revenue in USD (TTM)0.00
  • Net income in USD-1.65m
  • Incorporated1993
  • Employees--
  • Location
    Biostax Corp2431 Aloma Ave #124WINTER PARK 32792United StatesUSA
  • Phone+1 (407) 680-3097
  • Fax+1 (407) 641-8668
  • Websitehttps://www.biostaxcorp.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Lucy Scientific Discovery Inc16.73k-9.76m2.81m----34.57--167.72-6.34-7.210.01030.0460.0037--0.7276---215.45------49.97---58,360.55-----5.100.4615-------53.49------
Novelstem International Corp12.00k-4.19m2.81m15.00------234.41-0.0893-0.08930.0003-0.04160.0053--2.00---171.11---188.15-------32,373.50-----9.822.20--0.00---446.84------
Mosaic Immunoengineering Inc0.00-1.01m2.82m3.00---------0.1397-0.13970.00-0.81070.00----0.00-457.45-----------------35.84--------57.65------
Regen BioPharma Inc236.58k-851.69k2.86m1.00------12.09-0.2271-0.22710.0633-1.260.8644--3.98236,580.00-327.54-104.36---------378.93-275.00---1.32----0.441618.79-58.11------
Axim Biotechnologies Inc39.77k-8.06m2.91m6.00------73.29-0.0366-0.03660.0001-0.03110.0095----6,628.33-193.43-154.34---390.73-----20,265.75-36,362.71---0.62----345.05-27.38-29.10------
Veritas Farms Inc730.65k-6.15m2.95m17.00--14.57--4.04-0.1319-0.13190.01360.00130.08770.80647.8042,979.41-69.02-72.11-123.21-93.59-220.0924.07-787.27-177.790.1392-5.560.95---63.42-0.942723.68---52.93--
Navidea Biopharmaceuticals Inc610.00-8.81m3.00m11.00------4,922.18-0.2086-0.05470.00001-0.03270.00010.15290.006655.45-143.97-169.68---753.52-8,103.2891.34-1,411,062.00-1,938.530.5066-------87.65-48.49-46.75--63.23--
Biostax Corp0.00-1.65m3.01m-----------0.0198-0.01980.00-0.04560.00-------193.36-75.14---------------8.97--------53.32------
Revelation Biosciences Inc0.00-8.96m3.04m9.00--0.3206-----32.09-32.090.005.800.00----0.00-54.61---91.95--------------0.00------98.89------
Finch Therapeutics Group Inc107.00k-74.75m3.08m18.00--0.1347--28.81-46.59-46.590.066714.250.001--1.49---68.48---74.93-------69,863.55------0.00---87.57--34.80------
ENDRA Life Sciences Inc0.00-10.06m3.11m21.00--0.518-----1.93-1.930.000.54470.00----0.00-125.53-132.00-149.91-157.28------------0.005------23.67---19.46--
AccuStem Sciences Inc0.00-2.05m3.14m3.00---------0.1807-0.18070.00-0.18610.00----0.00-382.02--------------------------45.26------
Onconetix Inc58.47k-37.41m3.15m12.00------53.84-2.09-2.090.00342.630.001--0.63014,872.50-65.73---87.29---1,927.76---63,981.00--0.3185-19.880.1292-------176.78------
Optimus Healthcare Services Inc1.27m-7.79m3.20m17.00------2.53-0.1948-0.19480.0317-0.12910.2595--2.1674,453.53-159.79---2,228.37--77.90---615.77--0.1525-15.4121.18--------------
Data as of May 17 2024. Currency figures normalised to Biostax Corp's reporting currency: US Dollar USD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.